Injectable Targeted Therapy Market
Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2772
The various types of delivery vehicles used in injectable targeted therapy are liposomes, micelles, dendrimers, biodegradable particles and artificial DNA nanostructures. The applications of injectable targeted therapy are widely classified such as cardiovascular diseases, respiratory diseases and diabetes, but the primary application of injectable targeted therapy is in oncology. The injectable drugs primary target range included oncology, hormonal imbalances, autoimmune diseases, orphan/rare diseases (Cystic Fibrosis, Ribose-5-phosphate isomerase deficiency or RPI deficiency, Hemophilia and Wilson's disease) and others (allergies, aesthetic treatment hepatitis C and pain management).
The major drivers of injectable targeted therapy market are growing prevalence of senile disorders, sedentary lifestyle and increasing prevalence of cancer. According to World Health Organization (WHO), there were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide. While in same year 57% (8 million) of new cancer cases, 65% (5.3 million) of the cancer deaths and 48% (15.6 million) of the 5-year prevalent cancer cases occurred in the less developed regions from African and Asian continent. The prevalence of cancer is expected to increase and predicted to reach 24 million by 2035.
North America was observed to be the largest market for injectable targeted therapy as it’s a technologically advanced and premium therapy; the highest clinical research studies on targeted therapy market are going in the U.S. and Canada. Followed by Europe, the novel injectable target therapy is applied in most of the oncology cases in United Kingdom, Germany, France, Italy and Spain. Asia-Pacific and Rest of the World (RoW) consists of most of the emerging markets in the world such as India, China, Brazil and Mexico. The injected targeted therapy market in these geographies is currently at initial stages while in Japan this dosage form was observed to be the therapy of choice in most of the oncology patient treatment. Overall demand for targeted drugs is expected to grow in these regions especially after expected breakthroughs in cardiovascular, respiratory and diabetes applications.
Browse Report: http://www.transparencymarketresearch.com/injectable-targeted-therapy.html
The global trend observed in injectable targeted therapy market was increased deals in targeted drug delivery companies and ventures are expected to drive the partnership research programs in this therapy market. Some of the major players in Injectable targeted therapy market are Becton Dickinson, SHL Group, Ypsomed Holding AG, Terumo Medical Corp. , Schott AG, Owen Mumford Ltd and Antares Pharma Inc. Some market players currently researching on this technology are Actavis plc, Astra Zeneca plc, GlaxoSmithKline, Merus Laboratories International Inc., National Cancer Institute, Novartis AG, Amgen, Bristol-Myers Squibb, Unilife Corporation, Ligand Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and others.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Injectable Targeted Therapy Market here
News-ID: 343267 • Views: 413
More Releases from Transparency Market Research,
Electric Vehicle Charging Station Market to Change the Face of Automotive Indust …
Technology has found the answer to yet another topical problem in the automobile sector - high level of greenhouse gas emissions from automobiles contributing to global warming and climate change. With rapid technological advancements, battery powered vehicles are now a reality. With the introduction of electrically powered vehicles, new avenues have opened up for charging stations. The innovation in automobiles inventing high power electric vehicles are the biggest booster for
High-flow Nasal Cannula Market Review with Forecast Research Report 2017 - 2025
Some of the prominent participants in the global high-flow nasal cannula market are Fisher & Paykel Healthcare Limited, ResMed, Inc., Teijin Pharma Limited, Becton, Dickinson and Company, MEK-ICS CO., LTD., Teleflex Incorporated, Smiths Medical, Vapotherm, Inc., Flexicare Medical Limited, Salter Labs, Hamilton Medical, TNI medical AG, and Great Group Medical Co., Ltd. Of them, Fisher & Paykel Healthcare Limited emerged as the market leader in 2016. View Report: https://www.transparencymarketresearch.com/high-flow-nasal-cannula-market.html As per a
Industry Dynamics: Food Security Technologies Market Growth, Trends, Absolute Op …
Food security is the circumstance identified with the supply and access to food. Food security is characterized by Anderson in 1990 as access by all people consistently to enough food for a functioning solid life. As per World Food Summit food security exists when all people, constantly, have physical and monetary access to adequate, sheltered, nutritious food to meet their dietary needs and food inclinations for a functioning life. Food
Anti-aging Market Driven by Consumers’ Increasing Desire to Retain Youthful Ap …
According to a new market study published by Transparency Market Research, the Asia, Europe, and South America anti-aging market will log a CAGR of 9.3% from 2014 to 2020. As a result, the market’s valuation of US$15.28 bn in 2012 will increase to US$30.92 bn by 2020. The report, titled “Asia, Europe, and South America Anti-aging Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” is
More Releases for Pharma
Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Clomifene Citrate Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Clomifene Citrate Market" across the global, regional and country level. The report provides 360° analysis of "Clomifene Citrate Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Clomifene Citrate industry, and estimates the future trend of Clomifene Citrate market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business